EDGAR Filing Documents for 0000950170-24-018764

Form 8-K - Current report:

SEC Accession No. 0000950170-24-018764

Filing Date

2024-02-22

Accepted

2024-02-22 16:10:13

Documents

Period of Report

2024-02-21

Items

Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	atha-20240221.htm iXBRL	8-K	53029
2	EX-10.1	atha-ex10_1.htm	EX-10.1	410963
3	EX-99.1	atha-ex99_1.htm	EX-99.1	147150
4	GRAPHIC	img247042425_0.jpg	GRAPHIC	18091
	Complete submission text file	0000950170-24-018764.txt		833368

Data Files

Seq	Description	Document	Type	Size
5	XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT	atha-20240221.xsd	EX-101.SCH	26990
16	EXTRACTED XBRL INSTANCE DOCUMENT	atha-20240221_htm.xml	XML	4888

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011

Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501

Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39503 | Film No.: 24664805
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)